Biotech · Private company
Tcelltech Inc.
Track this companyFree. Adds Tcelltech Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- Anti-B7-H3 Chimeric Antigen Receptor T-Cell (CAR-T Cell) Injection/TX103Phase 1 · High-grade GliomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.PHASE1 · RECRUITING · started Sep 4, 2024ClinicalTrials.gov NCT06482905 · fetched Nov 12, 2026